A Phase 2 Trial of the Multi-targeted Tyrosine Kinase...

  • Main
  • 2015 / 08
  • A Phase 2 Trial of the Multi-targeted Tyrosine Kinase...
Clinical Cancer Research 2015 / 08

A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC)

Schlumberger, M., Jarzab, B., Cabanillas, M. E., Robinson, B. G., Pacini, F., Ball, D. W., McCaffrey, J. C., Newbold, K. L., Allison, R., Martins, R. G., Licitra, L., Shah, M. H., Bodenner, D., Elisei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1127
Date:
August, 2015
File:
PDF, 3.49 MB
english, 2015
Conversion to is in progress
Conversion to is failed